EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget’s disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget’s disease patients

Jiawen Yang, Yurong Chen, Xiuyuan Zhang, Ziyan Tong, Shanshan Weng, Ning Zhu, Ying Yuan

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03846-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Jiawen Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Paget Disease, Extramammary, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Clinical Research Center for CANCER, Provincial Key R&D Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesPaget Disease, ExtramammaryImmunotherapyHumansPrognosisFemaleMaleAgedMiddle AgedMolecular Targeted TherapyBiomarkers, TumorAged, 80 and overSEER ProgramSkin Neoplasms

Stichwörter der Autor:innen

Genes, erbB-2ImmunotherapyPaget Disease, ExtramammaryPrognosisSEER program

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Medical Oncology, Zhuji People's Hospital of Zhejiang province, Shaoxing, Zhejiang Province, China.
  • Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. zhuning2017@zju.edu.cn.
  • Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. zhuning2017@zju.edu.cn.
  • Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. yuanying1999@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Clinical Research Center for CANCER
  • Provincial Key R&D Program of Zhejiang Province

Zitieren

APA

Yang, J., Chen, Y., Zhang, X., Tong, Z., Weng, S., Zhu, N., & Yuan, Y. (2024). Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget’s disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget’s disease patients. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03846-8

Vancouver

Yang J, Chen Y, Zhang X, Tong Z, Weng S, Zhu N, et al. Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget’s disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget’s disease patients. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03846-8

BibTeX
@article{Yang2024,
  author = {Yang, Jiawen and Chen, Yurong and Zhang, Xiuyuan and Tong, Ziyan and Weng, Shanshan and Zhu, Ning and Yuan, Ying},
  title = {Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget’s disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget’s disease patients},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03846-8}
}
Kostenlos starten →